#USA #Delray Beach #MarketsandMarkets #Medical Device Manufacturing #IVD Devices

The Expanding Horizons of Medical Device Contract Manufacturing

The Medical Device Contract Manufacturing market is on a trajectory of significant growth, with a projected valuation of USD 135.47 billion by the year 2031. This surge signifies a robust Compound Annual Growth Rate (CAGR) of 9.6% from USD 85.59 billion in 2026, as reported by MarketsandMarkets™. This article delves into the key factors driving this expansion, market trends, and the implications for companies in the medical device sector.

Key Growth Factors

The demand for medical devices is escalating globally, mainly driven by the increasing healthcare needs of an aging population, coupled with the rising prevalence of chronic diseases. As healthcare demands rise, medical device companies are responding by outsourcing various tasks, including design, development, manufacturing, and assembly, to specialized contract manufacturers. This trend reflects a broader reliance on external expertise to handle complex production processes efficiently and cost-effectively.

Regulatory frameworks are also evolving, paving the way for established contract manufacturers equipped with robust quality control and compliance capabilities. As medical device companies seek partners capable of adhering to stringent regulatory standards across various markets, the pressure is on contract manufacturers to offer comprehensive solutions that ensure quality and regulatory compliance.

Market Segmentation

By region, the Asia Pacific market is expected to exhibit the highest growth rate, with a CAGR of 11.0% from 2026 to 2031. This growth stems from enhanced medical device manufacturing infrastructure, increased outsourcing by Original Equipment Manufacturers (OEMs), and rising investments in healthcare. Countries such as China and India are ramping up their domestic production capabilities, while Japan remains a significant market for advanced medical devices.

In terms of device types, the In Vitro Diagnostics (IVD) segment accounted for the largest share in 2025, holding 19.2% of the market. This segment is poised to maintain its dominance due to the increasing demand for diagnostic tests conducted across hospitals, laboratories, and homes. IVD suppliers frequently outsource the assembly of consumables and testing instruments to contract manufacturers with specialized cleanroom capabilities.

Services and Technology Integration

The device development and manufacturing services sector is forecasted to retain the largest share of the medical device contract manufacturing market throughout the forecast period, contributing 69.1% in 2025. This is because OEMs often prefer to allocate their workloads to contract partners skilled in component and finished device production—capabilities that require specialized tooling and validated procedures, typically outside the scope of OEMs’ in-house operations.

Furthermore, there is a notable trend towards services such as packaging and assembly, which are expected to grow rapidly at a CAGR of 10.5%. This increase correlates with the overarching demand for services that improve efficiency and streamline operations across the medical device supply chain.

Mergers and Acquisitions

Recent years have seen a rise in mergers and acquisitions within the medical device contract manufacturing sector. Significant deals include Integer Holdings' acquisition of Pulse Technologies and Jabil's acquisition of Pharmaceutics International, Inc.. These strategic moves are indicative of a bidding war to secure specialized capabilities necessary for meeting the demands of an expanding market focused on innovative healthcare solutions.

Future Outlook

The medical device contract manufacturing market is shifting from simple, high-volume production to a comprehensive array of complex, higher-risk device programs. Revenue is increasingly being directed toward higher-acuity programs and enhanced services—especially as the market capitalization rises from USD 85.59 billion in 2026 to USD 135.47 billion by 2031. With Asia Pacific claiming the most substantial share and rapid growth, it is essential for current and prospective manufacturers to navigate this shifting landscape to thrive in a competitive market.

In conclusion, as the demand for medical devices continues to grow, the collaboration between OEMs and contract manufacturers will be pivotal in meeting global healthcare challenges. The future looks promising for companies in this sector, particularly those who can leverage technological advancements and specialized capabilities to stay ahead in a dynamic marketplace.